Patents by Inventor Ale{hacek over (s)} Gavenda

Ale{hacek over (s)} Gavenda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8217061
    Abstract: Provided are sorafenib hemi-tosylate, polymorphs thereof, polymorphs of sorafenib tosylate, preparation thereof and pharmaceutical compositions thereof.
    Type: Grant
    Filed: January 19, 2009
    Date of Patent: July 10, 2012
    Assignee: Sicor Inc.
    Inventors: Ale{hacek over (s)} Gavenda, Alexandr Jegorov, Pierluigi Rossetto, Peter Lindsay MacDonald, Augusto Canavesi
  • Patent number: 8067423
    Abstract: The invention provides crystalline forms of isopropyl alcohol solvate of dasatinib, methods for their preparation, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: October 23, 2008
    Date of Patent: November 29, 2011
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Ondrej {hacek over (S)}imo, Ji{hacek over (r)}í Filip{hacek over (c)}ík, Alexandr Martaus, Alexandr Jegorov, Ale{hacek over (s)} Gavenda, Judith Aronhime, Pavel Vraspir, Tamás Koltai, Ji{hacek over (r)}í Faustmann, Roman Gabriel
  • Patent number: 8067421
    Abstract: Solvates and crystalline forms of imatinib mesylate are described. Further, methods for preparing such solvates and crystalline forms of imatinib mesylate are described.
    Type: Grant
    Filed: April 27, 2007
    Date of Patent: November 29, 2011
    Assignee: Sicor Inc.
    Inventors: Alexandr Jegorov, Miloslav Chudík, Judith Aronhime, Ale{hacek over (s)} Gavenda, Ji{hacek over (r)}í Faustmann
  • Patent number: 7977348
    Abstract: Solvates and crystalline forms of imatinib mesylate are described. Further, methods for preparing such solvates and crystalline forms of imatinib mesylate are described. The structure diagram below shows the chemical structure of imatinib mesylate.
    Type: Grant
    Filed: April 17, 2008
    Date of Patent: July 12, 2011
    Assignee: Sicor Inc.
    Inventors: Alexandr Jegorov, Miloslav Chudík, Judith Aronhime, Ale{hacek over (s)} Gavenda, Ji{hacek over (r)}í Faustmann
  • Patent number: 7973045
    Abstract: The invention provides anhydrous forms of dasatinib, methods for their preparation, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: June 14, 2010
    Date of Patent: July 5, 2011
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Ondrej {hacek over (S)}imo, Ji{hacek over (r)}í Filip{hacek over (c)}ík, Alexandr Martaus, Alexandr Jegorov, Ale{hacek over (s)} Gavenda, Judith Aronhime, Pavel Vraspír, Tamás Koltai, Ji{hacek over (r)}í Faustmann, Roman Gabriel